1[1]Chobanian AV,Bakris GL,Black HB,et al.The seventh report of the Joint National Committee on prevention,detection,evaluation,and treatment of high blood pressure.JAMA,2003,289(24):2560-2572.
2[2]Hansson L,Lindholm LH,Nisknen L,et al.Effect of angiotensinconverting-enzyme inhibition compared with convertional therapy on cardiovascular morbidity and mortality in hypertension:the Captopril Prevention Project(CAPPP)randomized trial Lancet,1999,353(9153):611-616.
1Hansson L,Lindholm LH,Niskanen L,et al.Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project ( CAPPP) randomised trial[].The Lancet.1999
2Anonymous.Effects of enalapril on mortality in severe congestive heart failure Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)[].The New England Journal of Medicine.1987
3Pitt B,Poole-Wilson PA,Segal R,et al.Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randomised trial-the Losartan Heart Failure Survival Study ELITE II[].The Lancet.2000
4Hansson L,Lindholm LH,Ekbom T,et al.Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swidish Trial in Old Patients with Hypertension-2 study[].The Lancet.1999
5Chaturvedi N,Sjolie AK,Stephenson JM,et al.Effect of Lisinopril on progression of retinopathy in normotensive people with type 1 diabetes[].The Lancet.1998
6The SOLVD Investigators.Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure[].The New England Journal of Medicine.1991
